ETP-ALL had a characteristic immunophenotype: CD1a and CD8-negative, CD5-negative, or dim (<75% of blasts positive) with one or more stem cell/myeloid markers positive (≥25% of blasts …

2016年4月14日 · Patients with ETP-ALL/LBL were identified on the basis of the following immunophenotypes: CD1a −, CD8 −, CD5 − (dim), and positivity for 1 or more stem cell or …

2023年12月14日 · ETP ALL is a distinct subtype of T-ALL that is consistently associated with a poor early treatment response to chemotherapy in pediatric and adult patients. 24-8 ETP ALL …

Early precursor T cell-acute lymphoblastic leukemia (ETP-ALL) is a rare entity characterized by chemo-resistance and a paucity of data regarding optimal management. We review here the …

2021年5月1日 · Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is characterized by a distinct immunophenotype (CD1a-negative, CD8-negative, CD5-negative or …

2023年12月14日 · Despite higher rates of induction failure for ETP (6.2%) and near-ETP (6.2%) than non-ETP (1.2%; P < .0001), all 3 groups showed excellent 5-year event-free survival …

ETP-ALL cases are currently identified through the phenotype of blast cells : CD1a-, CD8-, CD5- /weak, and positivity for one or more stem cell and/or myeloid antigens (CD117, CD34, HLA …

2021年2月27日 · Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is characterized by a distinct immunophenotype (CD1a-negative, CD8-negative, CD5-negative …

Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) and T-lymphoid/myeloid mixed phenotype acute leukemia (T/M-MPAL) are closely related entities and remain a therapeutic …

2021年12月20日 · Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a rare, distinct subtype of T-ALL characterized by genomic instability, a dismal prognosis and …